Pfizer at the 45th American Society of Clinical Oncology (ASCO) Annual Meeting
May 29-June 2, 2009 Orlando, FL
Breaking Pfizer News at ASCO 2009
- May 30, 2009 – Pfizer Data Identify Certain Lung Cancer Patients Who May Benefit from
Treatment with Figitumumab
- May 30, 2009 – Pfizer Presents Data With Novel Investigational Agents In Select Patient Groups With Non-Small Cell Lung Cancer
- May 29, 2009 – New Pfizer Data Helps to Identify Kidney Cancer Patients Who May Be Most
Likely to Benefit from Treatment
- May 13, 2009 – Pfizer to Present New Clinical Data Highlighting Customized Treatment Approaches For Difficult-To-Treat Cancers
- More ASCO News
Fact Sheets and Backgrounders
- ADVIGO 1016 Study Backgrounder (PDF)
- ADVIGO 1018 Study Backgrounder (PDF)
- Axitinib Fact Sheet (PDF)
- Brain Cancer Fact Sheet (PDF)
- Colorectal Cancer Fact Sheet (PDF)
- EGFRvIII Fact Sheet (PDF)
- Figitumumab (CP-751, 871) Fact Sheet ( (PDF)
- Gastrointestinal Stromal Tumor Fact Sheet (PDF)
- Hepatocellular Carcinoma Fact Sheet (PDF)
- IGF-1R Fact Sheet (PDF)
- Lung Cancer Fact Sheet (PDF)
- Metastatic Breast Cancer Fact Sheet (PDF)
- Metastatic Melanoma Fact Sheet (PDF)
- Pan HER Inhibitor Fact Sheet (PDF)
- PF-02341066 cMET ALK Fact Sheet (PDF)
- Pfizer Oncology Fact Sheet (PDF)
- Prostate Cancer Fact Sheet (PDF)
- Renal Cell Carcinoma Fact Sheet (PDF)
- Sutent Clinical Trials Fact Sheet (PDF)
- Sutent Fact Sheet (PDF)
- Tremelimumab Fact Sheet (PDF)
If you do not have Adobe® Acrobat® Reader, download it here. It is available without charge from Adobe®. This link is provided as a convenience. Pfizer is not responsible for the content of this linked page.
Stock Quote Disclaimer
20 minute delayed data provided by Comstock. Charts are provided by BigCharts and MarketWatch, Inc. Pfizer makes no claims concerning the accuracy of the information provided on these pages, and will not be held liable for any use of this information. Note: Historical and current stock price performance data is not necessarily indicative of future performance.
Stock Symbol: PFE Stock Exchange: NYSE
Stock Quote at: Nov 20 2009 4:00PM
| Last 18.36 | Change 0.25 |
| %Change | 1.38 | Vol. | 60,966,550 |
| Day High | 18.48 | 52 Wk. High | 18.48 |
| Day Low | 18.12 | 52 Wk. Low | 11.62 |
| Open | 18.15 | Mkt. Cap(Bil) | 148.16 |
| Prev. Close | 18.11 |
Our press kit provides information that might help you write stories or simply find out more about Pfizer.
Access Pfizer images and videos including product logos, headshots, and video clips.
- Contact Us
- Investors
- Sitemap
- Careers
- Business to Business
- Terms of Use
- Global Network
- Privacy Policy
Copyright © 2002–2009 Pfizer Inc. All rights reserved. This information is intended only for residents of the United States. The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries. Pfizer Inc is a pharmaceutical company committed to helping people improve their health by discovering and developing medicines.
